secwatch.observer — SEC 8-K summary
======================================

Issuer:     VIEMED HEALTHCARE, INC. (VMD)
CIK:        0001729149
Form:       8-K
Filed at:   2026-05-05T23:59:59+00:00
Accession:  0001729149-26-000028
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud

Viemed Healthcare reports Q1 2026 revenue of $75.4M, raises full-year guidance
------------------------------------------------------------------------------

- Net revenues increased 28% to $75.4 million for Q1 2026, up from $59.1 million in Q1 2025.
- Adjusted EBITDA for Q1 2026 was $14.3 million, a 12% increase versus the prior year quarter.
- Company repurchased 150,000 common shares at an average price of $9.29 per share during Q1.
- Ventilator patient count reached 12,089; PAP therapy patient count grew 57% to 35,938 as of March 31.
- Full-year 2026 net revenue guidance raised to $312–$320 million from prior $310–$320 million.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1729149/000172914926000028/0001729149-26-000028-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1729149/000172914926000028/vmd-20260505.htm
  HTML page:      https://secwatch.observer/filing/0001729149-26-000028

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer